Prez poll threatens to split UPA

June 15, 2012

kalam


New Delhi, June 14: The ruling United Progressive Alliance (UPA) on Thursday appeared headed for an internal confrontation over the next month’s presidential election as Trinamool Congress chief Mamata Banerjee declared that former president A P J Abdul Kalam would be her candidate for the top post.

Mamata announced that she will field Kalam if the Congress went ahead with the nomination of either Union Finance Minister Pranab Mukherjee or Vice-President Hamid Ansari.

The stage for the confrontation was set early during the day when the Congress rejected the possibility of nominating Prime Minister Manmohan Singh, or accepting Kalam or former Lok Sabha speaker Somnath Chatterjee as the UPA candidate. The three names were jointly proposed by Mamata and Samajwadi Party leader Mulayam Singh Yadav on Wednesday.

Congress general secretary in-charge of media affairs Janardhan Dwivedi came out publicly rejecting the three names, and objected to the Trinamool Congress’s announcement on Wednesday that Mukherjee and Ansari were the Congress’ first and second choice candidates respectively.

The Congress leadership held a series of meetings during the day to deliberate on the party’s nominee, with party chief Sonia Gandhi separately confabulating senior leaders like Mukherjee, Union Home Minister P Chidambaram and Defence Minister A K Antony separately and then together in the party’s core group.

The party leadership also held consultations with other UPA allies like the NCP chief Sharad Pawar and senior DMK leader T R Baalu. Both of them pledged support to the candidate the Congress would choose. The UPA leaders were expected to meet on Friday morning, to decide on a nominee.

While the Congress leadership rejected the three names proposed by Mamata, it scrupulously avoided naming either Pranab or Ansari as likely candidates. Indeed, the party clarified that Sonia had not mentioned to the Trimanool Congress leader during their meeting on Wednesday that Pranab and Ansari were its probable candidates in that order.

All that Sonia had told Mamata was that these two names had figured during the party’s consultations with its UPA allies.

Curiously, in the midst of all these, CPI leader A B Bhardhan, who was among the first to favour a woman candidate for the 2007 presidential election, proposed during the day that the next president should be a dalit woman. He did not take any names, but speculations were that he could be having Lok Sabha Speaker Meira Kumar in mind.

And, with Mamata on a confrontation course, the Congress seemed intent on reaching out to the Left parties for support in the election. Mukherjee reportedly spoke over phone to former West Bengal Chief Minister Buddhadeb Bhattacharjee, who in 2008 was against the CPM leadership’s decision to withdraw support to the UPA-I government.

However, the CPM leadership in the national capital maintained silence, though it criticised the UPA’s handling of the presidential nomination.

But, Mamata was categorical about her choice. She asserted that she will contest the UPA choice with Kalam as her candidate, particularly if the Congress choice were to be either Mukherjee or Ansari. She met Mulayam late in the evening after throwing up a challenge to the Congress.

While Mulayam, who had earlier favoured a seasoned politician for the post of President, maintained silence, Mamata declared: “Kalam is our and Mulayam Singh Yadav's number one candidate. He will be the best candidate."

She will not be attending the Friday’s scheduled UPA meeting. But said she was not walking out of the UPA either. “As far as the Trinamool is concerned, we are in the UPA. We don’t want to topple the government. But if the Congress does not want us, it is left to them. The ball is in the Congress’ court.”

Mamata’s latest stand may be music to the ears of the opposition NDA and other parties like the Biju Janata Dal and the AIADMK. They may be willing to endorse Kalam.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 1,2020

Allahabad, Mar 1: Shabista Khan, wife of suspended pediatrician Dr Kafeel Khan, fears that her husband's life is in danger.

In a letter written to the chief justice of the Allahabad High Court and senior government authorities, Shabista has sought security for her husband who is lodged in Mathura jail for allegedly delivering provocative speech during anti-CAA protest at Aligarh Muslim University.

"My husband is being mentally tortured in jail and is being subjected to inhuman behaviour," Shabista wrote in her letter to the chief justice of Allahabad High Court, additional chief secretary (home) and director general (jail), among others.

She said that she apprehended that an attempt could be made on her husband's life in jail and demanded adequate security for him.

She also demanded that her husband should be kept away from active criminals and lodged with common prisoners.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 8,2020

New Delhi, Jun 8: Delhi Chief Minister Arvind Kejriwal has gone into self-quarantine after developing sore throat and fever, and will get himself tested for COVID-19 on Tuesday, officials said on Monday.

They said the chief minister, who is also a diabetic, was feeling unwell since Sunday afternoon.

"He has mild fever and sore throat since Sunday afternoon. As advised by doctors, the chief minister will undergo COVID-19 test on Tuesday morning," officials said.

Officials said the CM had attended a Cabinet meeting on Sunday morning and thereafter, he did not attend any meeting.

The chief minister has been holding most of his meetings via video conferencing from his official residence for past two days.

This come as the number of coronavirus cases in the national capital crossed the 28,000-mark with 1,282 fresh infections while the death toll climbed to 812 on Sunday, a health bulletin issued by the Delhi government said. According to the health bulletin, the total number of COVID-19 cases in Delhi rose to 28,936 with 1,282 fresh cases.

A total of 51 fatalities were reported on June 6, the bulletin said, adding that these lives were lost between May 8 and June 5. It, however, said the cumulative death figure refers to fatalities where the primary cause of death was found to be COVID-19, according to a report of the Death Audit Committee on the basis of the case-sheets received from various hospitals.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.